HK1005736A1 - Intermediates of the mureidomycin group their preparation and their use - Google Patents

Intermediates of the mureidomycin group their preparation and their use

Info

Publication number
HK1005736A1
HK1005736A1 HK98104839A HK98104839A HK1005736A1 HK 1005736 A1 HK1005736 A1 HK 1005736A1 HK 98104839 A HK98104839 A HK 98104839A HK 98104839 A HK98104839 A HK 98104839A HK 1005736 A1 HK1005736 A1 HK 1005736A1
Authority
HK
Hong Kong
Prior art keywords
group
carbon atoms
mureidomycin
compound
tetrahydroisoquinolin
Prior art date
Application number
HK98104839A
Other languages
English (en)
Inventor
Tatsuo Haneishi
Masatoshi Inukai
Keiko Shimizu
Fujio Isono
Yoshiharu Sakaida
Takeshi Kinoshita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of HK1005736A1 publication Critical patent/HK1005736A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0217Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
HK98104839A 1987-11-20 1998-06-03 Intermediates of the mureidomycin group their preparation and their use HK1005736A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29335387 1987-11-20
JP29335287 1987-11-20

Publications (1)

Publication Number Publication Date
HK1005736A1 true HK1005736A1 (en) 1999-01-22

Family

ID=26559375

Family Applications (2)

Application Number Title Priority Date Filing Date
HK98102695A HK1003573A1 (en) 1987-11-20 1998-03-30 New antibiotics of the mureidomycin group their preparation and their therapeutic use
HK98104839A HK1005736A1 (en) 1987-11-20 1998-06-03 Intermediates of the mureidomycin group their preparation and their use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK98102695A HK1003573A1 (en) 1987-11-20 1998-03-30 New antibiotics of the mureidomycin group their preparation and their therapeutic use

Country Status (8)

Country Link
US (1) US5041423A (xx)
EP (2) EP0517345B1 (xx)
KR (2) KR0137779B1 (xx)
AT (1) ATE125256T1 (xx)
CA (1) CA1339595C (xx)
DE (2) DE3854205T2 (xx)
ES (2) ES2077345T3 (xx)
HK (2) HK1003573A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0487756A1 (en) * 1990-11-26 1992-06-03 Hoechst Aktiengesellschaft Antibiotics napsamycins A-D, process for their production and their use as pharmaceuticals
US6228842B1 (en) 1998-11-06 2001-05-08 Microcide Pharmaceuticals, Inc. Pacidamycins produced by Streptomyces coeruleorubidus
US6482921B1 (en) * 1999-01-28 2002-11-19 Essential Therapeutics, Inc. Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use
DE60116787T2 (de) * 2001-09-27 2006-08-24 Biocon Ltd., Hebbagodi Verfahren zur herstellung von pravastatin-natriumsalz mittels streptomyces flavidovirens dsm 14455
KR102302414B1 (ko) 2014-06-20 2021-09-16 주식회사 만도 임피던스 저감을 위한 피씨비와 섀시간의 그라운드 결합구조

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3341571A1 (de) * 1983-11-17 1985-05-30 Bayer Ag, 5090 Leverkusen Neue antibiotika, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und zwischenprodukte zu ihrer herstellung
GB8421279D0 (en) * 1984-08-22 1984-09-26 Baldwin J E Antibiotics
IT1184164B (it) * 1985-03-19 1987-10-22 Eniricerche Spa Triptidi ad azione ipotensiva e procedimento per la loro sintesi
KR950013857B1 (ko) * 1986-05-20 1995-11-17 상꾜 가부시끼가이샤 신규 항생물질 무레이도마이신 a, b, c 및 d 그의 제조 방법 및 치료학적 용도

Also Published As

Publication number Publication date
ES2054829T3 (es) 1994-08-16
DE3880092T2 (de) 1993-11-25
US5041423A (en) 1991-08-20
EP0317292A3 (en) 1990-07-25
CA1339595C (en) 1997-12-23
EP0317292B1 (en) 1993-04-07
HK1003573A1 (en) 1998-10-30
KR0137675B1 (ko) 1998-05-15
DE3854205D1 (de) 1995-08-24
KR0137779B1 (ko) 1998-05-15
DE3880092D1 (de) 1993-05-13
EP0517345B1 (en) 1995-07-19
DE3854205T2 (de) 1996-04-04
ATE125256T1 (de) 1995-08-15
ES2077345T3 (es) 1995-11-16
EP0317292A2 (en) 1989-05-24
EP0517345A1 (en) 1992-12-09
KR890008130A (ko) 1989-07-08

Similar Documents

Publication Publication Date Title
HK1012423A1 (en) Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase
FI911016A0 (fi) Menetelmä farmakologisesti aktiivisten substituoitujen -diketonien valmistamiseksi
HK1005736A1 (en) Intermediates of the mureidomycin group their preparation and their use
MY108849A (en) Novel compound
HUT47941A (en) Process for producing cefem compounds and new cefalosporin derivatives
ZA894470B (en) Substituted 3-aminosydnone imines,a process for their preparation and their use
ES2026548T3 (es) Un procedimiento para preparar penemos.
ES8205220A1 (es) Procedimiento para la obtencion de esteres del acido succi- nico de efecto antibacterial y antiprotozoal
ES8402303A1 (es) Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo (3.2.0) hepteno.
FI943596A (fi) Menetelmä terapeuttisesti käytt¦kelpoisten makrolidiyhdisteiden valmistamiseksi

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)